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When James Watson and Francis 
Crick reported the structure of DNA in 
1953, the mechanism of inheritance was 
instantly apparent. The complementary 
pairing of the DNA bases in the 
double helix, the pair famously wrote, 
“immediately suggests a possible 
copying mechanism for the genetic 
material.’’ The structure helped explain 
one of the central problems of modern 
biology: how does genetic material get 
faithfully replicated and then passed on 
from generation to generation? It was 
long thought that DNA is the only unit of 
inheritance.
Since then, it’s become clear that 
molecules of DNA are packaged into 
highly organized superstructures that 
themselves are inherited. These structures 
play a signiﬁ  cant role in the regulation 
of genes by preventing or facilitating 
protein–DNA interactions. In the 
eukaryotic cell (a cell with a nucleus), DNA 
exists as long threadlike molecules—a 
typical human cell contains some 6.5 
feet (2 meters) of DNA—that associate 
with a variety of proteins to form a 
network called chromatin. Genomic 
DNA wraps around specialized DNA-
packing proteins called histones to form 
nucleosomes, which condense chromatin 
into chromosomes and thereby inﬂ  uence 
chromosome behavior. Chromosomes are 
in turn packaged in increasingly higher 
levels of organization, with some parts 
being dispersed and others condensed. 
The most condensed region is called 
heterochromatin, or silent chromatin. 
Gene expression is largely silent in these 
regions, since the proteins required 
for transcription can’t access DNA to 
transcribe genes when chromosomes 
are so tightly packed. Other regions 
of chromosomes exist in an extended 
state, called euchromatin. This is the 
most genetically active state; with genes 
exposed, transcription can easily occur.
As chromatin shifts between these 
states, it inﬂ  uences gene expression, 
largely through the interactions of 
histones and large protein complexes 
that together assemble, remodel, and 
modify chromatin. Since proper cell 
function depends largely on activating 
the right gene at the right time, 
mechanisms have evolved that protect 
active genes from the intrusions of 
silencing structures like heterochromatin. 
Both euchromatin and heterochromatin 
respond to mechanisms that resist 
encroachments of the opposite state. 
One mechanism involves replacing 
“canonical’’ (that is, archetypal) histones 
with a histone variant. Previous 
work on yeast from Hiten Madhani 
and colleagues had shown that one 
histone variant, called H2A.Z, is found 
speciﬁ  cally in euchromatin and prevents 
silent chromatin from spreading into 
adjacent euchromatic regions. While 
researchers have characterized some of 
the mechanisms that deposit canonical 
histones onto euchromatin, they knew 
little about the mechanisms that deposit 
variant histones. In this issue of PLoS 
Biology, Jasper Rine, Hiten Madhani, and 
colleagues identify and characterize 
the function of a protein complex that 
helps deposit the variant H2A.Z onto 
euchromatin in yeast.
To investigate which proteins help 
direct H2A.Z to speciﬁ  c chromosomal 
locations, the authors isolated H2A.
Z, along with whatever proteins were 
associated with it, from yeast cell extracts. 
They determined that 15 proteins were 
true binding partners of H2A.Z and 
that 13 of them form a complex called 
SWR1-Com. The largest subunit of this 
complex, called Swr1p, belongs to a well-
known family of adenosine triphosphate 
(ATP)-dependent chromatin remodeling 
enzymes (they use the energy of ATP to 
power remodeling) that provide access 
to DNA in chromatin. Rine, Madhani, and 
colleagues show that protein subunits of 
SWR1-Com associate speciﬁ  cally with the 
histone variant H2A.Z. By comparing the 
gene expression proﬁ  les of yeast mutants 
lacking the H2A.Z-encoding gene with 
mutants lacking the Swr1p-encoding 
gene, the authors show that H2A.Z 
depends on the SWR1-Com protein 
complex to function. Most importantly, 
they show that SWR1-Com is required 
in living cells to deposit H2A.Z onto 
euchromatin. Interestingly, the authors 
note, SWR1-Com shares subunits with 
a histone-acetylating enzyme involved 
in the regulation of transcription (called 
the NuA4 histone acetyltransferase) and 
with another chromatin remodeler, which 
suggests that biochemical modiﬁ  cations 
of the subunits on histone “tails’’ may play 
a role in replacing H2A with H2A.Z.
This histone–protein complex, the 
authors conclude, represents a chromatin 
remodeling machine with a novel 
function, revealing a new role for Swr1p-
type enzymes and a novel mechanism 
of genome regulation. By preventing 
the spread of silent chromatin into 
transcriptionally active chromosomal 
regions—the result of the interaction 
described here—this mechanism 
allows the cell’s gene expression 
program to operate with precision 
and on schedule. Since chromosomes 
can be inherited by daughter cells in 
this active state, such mechanisms 
ensure that gene expression programs 
essential for ongoing fundamental 
processes like embryogenesis and 
cellular differentiation proceed without 
interference.
Kobor MS, Venkatasubrahmanyam S, 
Meneghini MD, Gin JW, Jennings JL, et 
al. (2004) A protein complex containing 
the conserved Swi2/Snf2-related ATPase 
Swr1p deposits histone variant H2A.Z 
into euchromatin. DOI: 10.1371/journal.
pbio.0020131
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With billions of cells in the adult human body, all replicating and 
dividing in an environment laden with toxins, radiation, and free 
radicals, a certain amount of DNA damage is guaranteed to occur. 
Fortunately, all organisms have built-in checkpoints throughout 
the cell cycle that prevent such mistakes from propagating. At 
the G1 checkpoint during cell division, for example, molecules 
survey nuclear DNA for errors and breaks before the cell is deemed 
ﬁ  t to undergo S phase, the DNA replication stage. If damage is 
found, enzymes either work to repair it or, in some cases, trigger 
programmed cell death, or apoptosis. But 
when checkpoints fail, and DNA damage 
is left unrepaired, disease such as cancer 
can result. A better understanding of 
these events, as provided, for example, by 
Vincenzo Costanzo and colleagues in this 
issue, will consequently lead to a better 
understanding of the mechanisms that 
give rise to cancer.
A serious form of DNA damage, called a 
double strand break (DSB), cuts the helix 
clean through—a far worse scenario than 
if just one strand slips free. In response 
to a DSB, the cell recruits a signaling 
protein called ATM and a three-protein 
complex called MRN, whose components 
selectively bind to broken DNA ends. A malfunction of this 
signal and repair pathway is dire. People who suffer from the 
genetic disease ataxia-telangiectasia (A-T) lack a functioning 
ATM molecule and therefore cannot properly handle DSBs or 
successfully navigate the G1 checkpoint. This condition leads to 
a host of problems, including abnormal chromosomes, deﬁ  cient 
immune function, and a predisposition to cancer. A-T-like disease 
(ATLD), another rare genetic condition, has very similar symptoms. 
The only difference is that the protein missing is Mre11, a subunit 
of MRN. While recent work on the cellular level has indicated that 
MRN activates ATM, the biochemical relationship between these 
proteins has yet to be fully understood.
Studying these two molecules using traditional biochemical 
assays is difﬁ  cult because knocking out the activity of these 
proteins is lethal to many cells. Costanzo and colleagues used 
a novel test system of cell-free frog extracts and found that 
Mre11 is necessary for both ATM activation and for the formation 
of large protein–DNA complexes apparently responsible for 
triggering the cascade of signaling molecules underlying the 
DNA damage response at the G1 checkpoint.
The frog extract system allowed the team to manipulate 
the presence or absence of Mre11 
and accurately measure the response 
triggered by the addition of 
fragmented bits of DNA (simulating 
naturally occurring DSBs). As 
predicted, without a functional 
Mre11 protein, ATM was not activated 
and there was no response. By 
simply adding the protein Mre11 
back to the mixture, the damage 
response was restored. But when the 
researchers added a mutant form of 
Mre11, still capable of performing its 
essential tasks in another stage of 
the cell cycle—DNA replication—the 
G1 damage response remained 
suppressed. This mutant form of the Mre11 protein lacks the 
C-terminal, or DNA-binding, end.
Costanzo and colleagues also found that this DNA-binding 
end is required for the assembly of DNA–ATM–MRN complexes 
in the presence of fragmented DNA and seems to direct the 
entire damage response. This work helps to explain the similarity 
between patients with A-T and those with ATLD, and hints at the 
formation of a large “signaling’’ complex that helps to orchestrate 
the crucial response to DBSs in DNA.
Costanzo V, Paull T, Gottesman M, Gautier J (2004) Mre11 assembles 
linear DNA fragments into DNA damage signaling complexes. DOI: 
10.1371/journal.pbio.0020110
The Mre11 Protein Is Necessary for DNA Damage Response
Model for Mre11 complex bridging DNA 
molecules
Dissecting the Complexities of Glucose Signaling in Yeast
An organism’s survival depends on 
developing effective strategies for 
identifying and adapting to available 
sources of food. Even organisms as small 
as the budding yeast Saccharomyces 
cerevisiae can respond in a complex 
way to the presence of different energy 
sources. While yeast can metabolize 
many different sugars, glucose provides 
the highest energy yield. To achieve 
this energy efﬁ  ciency, yeast cells rely 
on specialized enzymes and metabolic 
states that mediate glucose metabolism 
by sensing and responding to this sugar. 
The presence of glucose triggers a rapid 
and dramatic change in the expression 
of about a quarter of S. cerevisiae’s 5,500 
genes.
Many of the cellular participants in the 
glucose “sense-and-response’’ pathway 
have been identiﬁ  ed, but their exact 
relationships remain unknown. The 
gene expression response to glucose 
has been previously characterized 
through the use of a cDNA microarray, 
which allows simultaneous assessment 
of the transcriptional state of every 
gene. In research reported in this issue, 
James Broach and his colleagues at 
Princeton University have attempted to 
connect the individual components in 
this complex pathway by performing 
microarray analysis on a series of mutants 
(yeast strains with defects in speciﬁ  c 
proteins). They link certain portions of the 
response to known proteins and begin 
to understand how the pieces of this 
pathway ﬁ  t together.
The researchers initially focused on 
two proteins, called Ras2 and Gpa2. These 
proteins have been previously implicated 
in the transcriptional response to glucose 
and are members of a well-established 
family of signaling proteins. To investigate 
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the roles of these proteins in the response, 
the researchers used mutants of Ras2 and 
Gpa2 that could be activated on demand 
and then performed microarray analysis to 
see which genes responded to activation 
of these proteins. They found that even in 
the absence of glucose, activation of either 
protein induced a transcriptional proﬁ  le 
almost identical to the proﬁ  le generated in 
yeast exposed to glucose. This shows that 
the complex and dramatic transcriptional 
response to glucose can be recapitulated 
by the activation of a single protein.
The Ras2/Gpa2 pathway, however, 
is not the whole story. The group then 
went on to show that not all glucose-
responsive genes are regulated in the 
same manner. They found that another 
pathway, independent of Ras2 and 
Gpa2, is able to elicit a portion of the 
transcriptional response to glucose. The 
partial redundancy of these pathways is 
a curious phenomenon and bears further 
investigation.
The authors have achieved an 
initial step in mapping the topology 
of the intricate signaling pathway (or 
pathways) involved in the response to 
glucose. Furthermore, the approach—
that of using microarray analysis of 
mutants in a pathway to deduce the 
mechanisms of regulation—will be 
useful in efforts to map other complex 
responses in yeast as well as in higher 
organisms.
Wang Y, Pierce M, Schneper L, Güldal 
CG, Zhang X, et al. (2004) Ras and Gpa2 
mediate one branch of a redundant glucose 
signaling pathway in yeast. DOI: 10.1371/
journal.pbio.0020128
Formation of the central nervous system has long been 
thought to result from an induction process, whereby signals 
emanating from a portion of the dorsal endomesoderm (the 
inner middle layer of the developing embryo), known as the 
Spemann–Mangold organizer, instruct cells of the overlying 
dorsal ectoderm (outer layer) to become neural instead 
of epidermal. The Spemann–Mangold organizer was itself 
deﬁ  ned in Spemann and Mangold’s seminal 1924 publication 
as a portion of the dorsal “vegetal’’ half (also known as the 
endodermal, or inner, layer) of a gastrulating Xenopus frog 
embryo that could induce the differentiation of a whole new 
axis, including a new central nervous system, when grafted 
into an abnormal location. (Gastrulation is the process that 
establishes the basic body plan of the organism as cells arrange 
themselves into three embryonic germ layers: the endoderm, 
mesoderm, and ectoderm.) From these and later experiments, 
the notion emerged that neural induction in Xenopus takes 
place at gastrulation and requires signals from the mesoderm. 
(The Spemann–Mangold organizer is itself derived from the 
endomesoderm.)
Now Hiroki Kuroda, Oliver Wessely, and Edward De Robertis 
challenge this model by demonstrating that a group of cells 
in the dorsal region of the prospective ectoderm is fated 
to become neuronal as early as the blastula stage (which 
precedes gastrulation) and that these cells can express 
their neural character in the absence of any mesodermal 
influence. The authors call this group of cells the BCNE 
(blastula Chordin- and Noggin-expressing) center, based on 
their previous observation that this center expresses the 
proteins Chordin and Noggin at the blastula stage. Chordin 
and Noggin are also expressed later in the Spemann–
Mangold organizer and are among the key signals that 
mediate neural induction by the organizer. The presence of 
the neural inducers in blastula ectodermal precursor cells 
prompted the authors to test these cells’ neural potential. 
They first demonstrated that BCNE cells normally give rise 
to the anterior portion of the brain, which confirms these 
cells’ neural fate. Moreover, when cultured in vitro, BCNE cells 
taken from tissue begin to express neural protein markers, 
even when extra care is taken to prevent any contact with 
mesodermal precursors. It therefore appears that BCNE cells 
are already specified to become neural by the blastula stage, 
before the Spemann–Mangold organizer forms.
To further demonstrate BCNE cells’ independence from 
mesodermal signals, the authors generate embryos without a 
mesoderm. Having previously observed that such embryos do 
develop a central nervous system, Kuroda et al. now demonstrate 
that this intrinsic neuronal potential depends on Chordin and 
Noggin expression in BCNE cells. The model that emerges from 
these experiments suggests that neural induction begins at the 
blastula stage, with Chordin and Noggin signaling within the 
BCNE center and may later be consolidated or modulated by 
signals emanating from the organizer.
What of the endodermal portion of the Spemann–Mangold 
organizer? It expresses a secreted protein called Cerberus that 
is involved in development of the head. The authors show that 
abolishing Cerberus function in the prospective endoderm 
results in headless embryos. Complete brain removal can also 
be achieved by partially inhibiting Cerberus function, so long 
as Chordin is simultaneously inhibited in the dorsal ectoderm. 
It is therefore likely that while BCNE cells harbor an intrinsic 
neural potential, neural induction in a living organism occurs via 
cooperation between the germ layers.
Kuroda H, Wessely O, De Robertis EM (2004) Neural induction in 
Xenopus: Requirement for ectodermal and endomesodermal signals 
via Chordin, Noggin, β-Catenin, and Cerberus. DOI: 10.1371/journal.
pbio.0020092
Neural Induction without Mesoderm in Xenopus
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The astounding diversity of 
life—different body shapes and sizes, 
physiologies, and behaviors—stems from 
the accumulation of genetic changes 
through the process we call evolution. 
But catching a glimpse into the process 
of evolution at the gene level is difﬁ  cult, 
mostly because signiﬁ  cant changes to 
the plant and animal species of today 
happened a long time ago. Nevertheless, 
biologists are keen to understand exactly 
how evolution progresses. For example, 
how many genes must be altered before 
noticeable shifts in appearance can be 
seen? Is evolution the result of changes in 
many genes with small additive effects, or 
of just a few mutations that exert a strong 
inﬂ  uence?
To tackle these questions, Pamela 
Colosimo and colleagues turned to 
threespine stickleback ﬁ  sh, a longtime 
favorite model system of evolutionary 
biologists because of its relatively 
youthful evolutionary history. At the end 
of the last ice age 10,000 years ago, when 
glaciers all over the Northern Hemisphere 
began to melt, small populations of these 
originally marine-dwelling ﬁ  sh became 
trapped in newly formed lakes. There, 
isolated stickleback colonies adapted 
to new ecological conditions—different 
predators, food availability, water 
chemistry, and temperature—and 
now look distinctly different from their 
marine ancestors. One of the most 
obvious changes in appearance is in 
their body armor—they come in three 
distinct types, or “morphs.’’ Marine 
sticklebacks are covered from head to 
tail with rows of tightly packed boney 
plates (a complete morph), while those 
found in freshwater lakes have fewer 
body plates (a partial morph) or almost 
none at all (a low morph). Colosimo and 
colleagues found that a single region of 
the genome is largely responsible for the 
dramatic changes in plate morph, and 
that this is true for two widely separated 
populations of independently evolving 
freshwater sticklebacks.
To uncover the genomic regions that 
affect armor, Colosimo’s team crossed 
fully armored marine sticklebacks from 
Japan with deep-water, or benthic, low 
morph ﬁ  sh from Paxton Lake in British 
Columbia, Canada. They then “mapped’’ 
the full genome of second 
generation offspring using 160 
known genetic markers, or loci, 
as guideposts for distinct regions 
of the genome—loci that are 
inherited along with differences 
in the overall type of plating, and 
individual plate number and size.
The team found that one 
such locus explained 75% of 
the variation in plate morphs. 
Offspring that carried two 
alleles—versions of the gene—
from their marine grandparents, 
genotype AA, were almost 
always fully plated. Those that 
inherited two copies of the allele 
from their benthic progenitors, 
aa, were mostly low morphs 
with very little plating. And Aa 
heterozygous ﬁ  sh (with one 
allele from each population) 
had mostly full or partial plates. 
Colosimo and colleagues also 
found three other regions in 
the genome that signiﬁ  cantly 
affected the number and size of 
plates. These modiﬁ  ers had an 
additive effect—the more benthic alleles 
inherited, the fewer and smaller the 
plates; more marine alleles caused a trend 
toward greater armor.
But is this genetic architecture the 
same for every independently evolving 
population of lake-bound sticklebacks in 
North America? Or did the geographically 
isolated freshwater groups loose their 
plates through mutations in different 
genes? Colosimo and colleagues 
mapped the genome of a population of 
sticklebacks from Friant, California, which 
is 800 miles away from Paxton Lake, and 
found that the same major locus seemed 
to be controlling plate morph there as 
well. Crossing a low morph from Friant 
with a low morph from Paxton yielded 
only offspring with very little armor. 
Further, some of the modiﬁ  ers uncovered 
in the Paxton ﬁ  sh were also acting on the 
Friant sticklebacks. So, though these two 
populations of ﬁ  sh have been separated 
for 10,000 years, loss of armor in both 
groups probably stemmed from changes 
in the same genetic pathway.
Without knowing the precise 
sequence of these genes, it is impossible 
to tell exactly how and when the 
alleles that reduce armor arose. Small 
numbers of individuals with genes 
causing less plating could have been 
present in ancestral populations of 
marine sticklebacks when they were 
originally locked in newly formed lakes. 
Alternatively, reduced armor could have 
arisen independently in different lakes 
following isolation if, for example, some 
genes that control armor are predisposed 
to mutation, or certain armor-related 
mutations are more advantageous 
than others. But however it happened, 
this study clearly shows that dramatic 
morphological evolution can result from 
a small number of genetic changes. 
Further study of this classic system 
should provide a detailed picture of the 
genes involved, and of the molecular 
events that underlie morphological 
changes in natural populations evolving 
in new environments.
Colosimo PF, Peichel CL, Nereng K, 
Blackman BK, Shapiro MD, et al. (2004) 
The genetic architecture of parallel armor 
plate reduction in threespine sticklebacks. 
DOI: 10.1371/journal.pbio.0020109
Single Locus Controls Majority of Armor Evolution in Two Populations of Sticklebacks
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Since small RNA molecules were 
discovered just over ten years ago, it’s 
become clear that these once overlooked 
bits of genetic material play a decidedly 
large role in controlling gene expression. 
Though typically just 21 to 24 nucleotides 
long, small RNAs regulate a diverse array 
of cellular processes, from developmental 
patterning and genome rearrangement 
to antiviral defense. They typically 
accomplish these tasks by targeting 
speciﬁ  c nucleotide sequences to shut 
down gene expression.
Found in both plants and animals, 
small RNAs come mainly in two classes—
microRNA (miRNA) and short interfering 
RNA (siRNA). miRNAs arise from non-
protein-coding transcripts that adopt 
extended “fold-back’’ structures, which are 
then cleaved by enzymes called Dicer or 
Dicer-like (DCL). siRNAs, on the other hand, 
arise from perfectly base-paired double-
stranded RNA, which are also cleaved 
by Dicer. Some siRNAs require enzymes 
called RNA-dependent RNA polymerases 
(RdRp). miRNAs and many types of siRNAs 
function post-transcriptionally—that 
is, they affect genes that have been 
expressed, or transcribed, into RNA—to 
guide cleavage or prevent translation 
into protein. In plants and some animals, 
this post-transcriptional RNA interference 
(RNAi) acts as an adaptive antiviral 
response, among other things. siRNAs 
can also “silence’’ gene expression by 
altering chromatin—the DNA-protein 
complex into which chromosomes 
assemble—and preventing transcription. 
It is thought that chromatin silencing 
acts as a genome defense mechanism, 
guarding against potential damage from 
mobile genetic elements or invasive DNA 
(say, from a virus) by keeping genes in 
the tightly coiled, and thus inaccessible, 
“heterochromatic’’ state.
While much remains to be learned 
about the mechanisms and pathways 
that govern small RNAs, it’s becoming 
clear that they add an important layer 
of regulation and ﬂ  exibility to gene 
expression. Now a team led by James 
Carrington at Oregon State University 
and Steve Jacobsen at the University of 
California at Los Angeles demonstrates 
that plants have evolved multiple 
systems to produce distinct classes of 
small RNAs with specialized regulatory 
and defensive functions. The ﬁ  rst 
generates miRNAs; the second produces 
siRNAs that regulate chromatin structure; 
and the third generates siRNAs in 
response to viral infections. Each system 
requires a unique spectrum of functions 
of three different DCL proteins; the siRNA 
systems each function in coordination 
with one of several RdRp proteins. The 
researchers propose that the expansion 
and subsequent diversiﬁ  cation of these 
proteins, which occurred in plants but not 
in many animals, has contributed to the 
diversiﬁ  cation of specialized small RNA-
directed pathways.
Working in Arabidopsis thaliana, 
a favorite model organism for plant 
biologists, Zhixin Xie et al. analyzed a 
series of mutants with nonfunctional 
dcl and rdr genes, as well as a few other 
mutants of interest, to determine how the 
small RNAs responded to loss of these 
proteins. Two mutations (one in a dcl 
gene and one in another gene) affected 
the miRNAs, either impairing their 
function or reducing their populations. 
None of the RdRp proteins had any effect 
on miRNAs. The researchers performed 
the same type of genetic analyses on 
siRNAs and found that a different DCL 
mutant caused a reduction in one class of 
siRNAs and that an RdRp mutant nearly 
eliminated these populations of siRNAs.
The diversity of siRNAs produced by the 
Arabidopsis genome reveals an important 
role in genome maintenance, expression, 
and defense, the authors conclude. Given 
that large numbers of siRNAs arise from 
highly repeated sequences—such as 
those introduced by viruses or mobile 
genetic elements—it may be that the 
cell senses such “invasive’’ sequence 
duplication events and enlists siRNAs 
to run interference by silencing these 
potentially damaging sequences. In this 
way, chromatin-associated siRNAs may 
offer an additional line of defense against 
invasive sequences, on top of that offered 
by post-transcriptional RNAi—a dual 
adaptive advantage since a fast-spreading 
virus or over-proliferating transposon (also 
known as a jumping gene) could wreak 
havoc on a plant population.
Whatever other roles small RNAs 
may play in genome regulation—they 
have also been implicated in regulating 
growth and development—their 
primary responsibility appears to be 
blocking gene expression. Whether 
they accomplish that by controlling 
chromosome activity to prevent 
gene transcription or by inhibiting 
or degrading RNA transcripts to 
block translation into protein, small 
RNAs appear to make wide-ranging 
contributions to the overall gene 
expression program of the cell.
Xie Z, Johansen LK, Gustafson AM, 
Kasschau KD, Lellis AD, et al. (2004) 
Genetic and functional diversiﬁ  cation 
of small RNA pathways in plants. DOI: 
10.1371/journal.pbio.0020104
Small RNA Pathways in Plants
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Biologists have long known that the African great apes (including the chimpanzee, 
bonobo, and gorilla) are our closest relatives, evolutionarily speaking. The recent release 
of the chimp draft genome sequence conﬁ  rms this relationship at the nucleotide 
level, showing that human and chimp DNA is roughly 99% identical. Given the genetic 
similarity between human and nonhuman primates, the next big challenge is to identify 
those changes in the human genotype (the genetic complement of an organism) that 
generated the complex phenotype (the physical manifestation of gene expression) that 
distinguishes humans from the great apes. For example, modern humans have larger 
brains and a larger cerebral cortex than both nonhuman primates and their forebears, 
the early hominids. Elucidating the molecular mechanisms that account for this 
expansion will provide insight into brain evolution.
One way to ﬁ  gure out which genes are involved in a physiological process is to 
analyze mutations in the genotype that generate an abnormal phenotype. Such efforts 
are easier in the relatively rare instance that 
one gene affects a single trait. Mutations 
in the ASPM gene cause microencephaly, a 
rare incurable disorder characterized by an 
abnormally small cerebral cortex. Since the 
microencephalic brain is about the same 
size as the early hominid brain, researchers 
hypothesized that ASPM—whose normal 
function is unclear—may have been a 
target of natural selection in the expansion 
of the primate cerebral cortex. Last year, 
researchers showed that selective pressure 
on the ASPM gene correlated with increased 
human brain size over the past few million 
years, when humans and chimps diverged 
from their common ancestor. Now, Vladimir 
Larionov and colleagues report that the 
selective pressure began even earlier—as 
far back as 7–8 million years ago, when 
gorillas, chimps, and humans shared a 
common ancestor.
The researchers used a newly developed 
technology (called TAR-cloning) to 
extract specialized cloning agents in yeast (called yeast artiﬁ  cial chromosomes, or 
YACs) containing the entire ASPM gene, including promoter and intronic (noncoding) 
sequences, from chimpanzees, gorillas, orangutans, and rhesus macaques. They 
sequenced these YACs to determine the complete genomic sequence of the ASPM gene 
from each species. Next, they characterized sequence changes among these species, 
based on whether the resulting substitutions in amino acids produced changes in the 
ASPM protein, to determine how fast the protein was evolving. Larionov and colleagues 
found that different parts of the protein evolved at different rates, with the rapidly 
evolving sequences under positive selection (beneﬁ  cial mutations were selected for, 
or retained) and the slowly evolving sequences under “purifying’’ selection (signiﬁ  cant 
disruptions were jettisoned). Positive selection on genes is one important way to drive 
evolutionary change.
By reconstructing the evolutionary history of the ASPM gene, Larionov and colleagues 
show that the increase in human brain size—which began some 2–2.5 million years 
ago—happened millions of years after the gene underwent accelerated selective 
pressure. The ASPM gene, they conclude, likely plays a signiﬁ  cant role in brain evolution. 
The next big challenge will be identifying the forces that preferentially acted on the 
human genotype to kick-start the process of brain expansion, forces that promise to 
shed light on what makes us human. New genomic technologies like TAR-cloning will 
likely accelerate this process.
Kouprina N, Pavlicek A, Mochida GH, Solomon G, Gersch W, et al. (2004) Accelerated 
evolution of the ASPM gene controlling brain size begins prior to human brain expansion. 
DOI: 10.1371/journal.pbio.0020126
Evolutionary History of a Gene Controlling Brain Size
MRIs of a normal individual (bottom left) 
and a patient with microcephaly caused by 
an ASPM mutation (bottom right). Primate 
skulls provided courtesy of the Museum of 
Comparative Zoology, Harvard University.
A Gene That Directs the 
Regeneration of Injured Muscle 
from Adult Stem Cells
If the United States’ Human Cloning 
Prohibition Act of 2003 (H.R. 534) 
becomes law, American researchers 
practicing any form of cloning could face 
up to ten years in prison and a minimum 
$1 million ﬁ  ne. The bill criminalizes a 
research procedure, called somatic cell 
nuclear transfer, that involves removing 
the DNA from a fertilized egg and 
replacing it with the DNA of a body 
(soma) cell. While the procedure could 
theoretically be used to clone a human 
being, used therapeutically its great 
promise lies in yielding a renewable 
source of stem cells to repair and 
regenerate tissue damaged by disease or 
injury. Embryonic stem cells appear most 
suited to this task, but some researchers 
are ﬁ  nding that adult stem cells could 
perform similar duties in certain tissues. 
And adult stem cells, it appears, are 
responsive to genetic manipulation. 
H.R. 534 does not threaten researchers 
working with adult stem cells.
The precise origin of adult stem cells 
is unclear, though some propose that 
they are “set aside’’ during embryonic 
development and sequestered in mature 
tissue. These cells, which can make 
identical copies of themselves or give 
rise to specialized cells, serve primarily to 
replace damaged or injured cells. Skeletal 
muscle has a remarkable capacity to 
regenerate following exercise or injury 
and harbors two different types of adult 
stem cells to accomplish the job: satellite 
cells and adult stem cells that can be 
isolated as side population (SP) cells. 
Like embryonic stem cells, the adult cells 
commit to a certain fate once particular 
genes are activated.
It was thought that only satellite 
cells could mediate skeletal muscle 
regeneration until recently, when 
scientists found that adult stem cells 
not only participate in muscle tissue 
regeneration but also spawn satellite 
cells. A certain population of these stem 
cells, which are recognized by the cell 
surface proteins CD45 and Sca1 (stem cell 
antigen-1), is involved in normal muscle 
tissue repair, but is only triggered into 
the muscle cell development pathway 
by injury. The question then arises: what 
molecular factors turn these adult stem 
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Rudnicki and colleagues have shown 
that one gene, Pax7, plays a crucial role 
in directing the differentiation of these 
adult stem cells into skeletal muscle cells.
In previous studies, Rudnicki’s group 
demonstrated that Pax7 is required to 
turn adult stem cells into myogenic cells 
during regeneration. Here, the researchers 
worked with mouse models and in vitro 
experiments to investigate which cell 
populations Pax7 targets and how the 
gene initiates muscle cell formation in 
injured tissue. They show that CD45:Sca1 
cells taken from regenerating muscle in 
mice lacking the Pax7 gene could not 
become muscle cells. And they show that 
by putting Pax7 back into CD45:Sca1 cells 
taken from uninjured muscle, they can 
generate a population of proliferating 
myoblasts that readily differentiate 
into muscle cells. When CD45:Sca1 cells 
engineered to express Pax7 proteins 
were injected into the muscles of 
mice lacking dystrophin (the protein 
defective in muscular dystrophy), the 
cells differentiated, forming dystrophin-
expressing muscle cells in the defective 
muscle. This shows that engineered 
“donor cells’’ can differentiate in living 
tissue and help repair dystrophic muscle. 
When the researchers injected Pax7 
(using a gene therapy virus) into the 
damaged muscle of mice lacking Pax7, 
they observed the production of muscle-
forming cells that not only gave rise to 
differentiated muscle cells, but also aided 
in tissue repair.
The researchers argue that these 
results “unequivocally establish’’ 
Pax7 as a key regulator of muscle cell 
differentiation in speciﬁ  c populations 
of adult stem cells during muscle tissue 
regeneration. If therapeutic strategies 
that activate Pax7 in adult stem cells can 
turn them into muscle cells, effectively 
replenishing injured or diseased muscle 
tissue, there’s hope of reversing the 
debilitating effects of progressive muscle-
wasting diseases. Though the clinical 
efﬁ  cacy of such an approach will require 
intensive investigation, the results on 
these adult stem cells are encouraging—
especially in this political climate.
Seale P, Ishibashi J, Scimè; A, Rudnicki 
MA (2004) Pax7 is necessary and sufﬁ  cient 
for the myogenic speciﬁ  cation of CD45+:
Sca1+ stem cells from injured muscle. DOI: 
10.1371/journal.pbio.0020130
Pax7-infected stem cells rescue dystrophin 
expression
The heart starts beating and pumps blood through the body 
long before it has achieved its mature architecture. In theory, this 
provides a chance for cardiac function to sculpt cardiac structure, 
an intriguing possibility for developmental biologists, and one 
of potentially great clinical import for cardiologists seeking 
to identify the causes of (often fatal) cardiac anomalies. In this 
issue of PLoS Biology, Thomas Bartman et al. use the powerful 
tools afforded by zebraﬁ  sh genetics to dissect the early steps of 
heart valve formation. In the process, they provide evidence for a 
causal relationship between the early function of the heart and 
its ﬁ  nal structure.
At the time of its ﬁ  rst beat, the vertebrate heart is little more 
than a tube, lined on its outside by a 
myocardial cell layer whose contractions 
(the heartbeats) power blood ﬂ  ow, and 
on its inside by an endocardial cell layer, 
an extension of the inner wall of the 
connecting blood vessels. What it lacks still 
are valves and septae, the ﬁ  brous gates 
that subdivide the mature heart into atrial 
and ventricular chambers, and control 
the directionality of blood ﬂ  ow. These 
structures derive from the endocardium 
in a process that begins—shortly after 
the establishment of blood ﬂ  ow—with 
the local accumulation of endocardial 
cells into what are known as endocardial 
cushions (ECs).
The zebraﬁ  sh lends itself well to 
large-scale genetic screens, and powerful 
genomic tools are now available to 
efﬁ  ciently identify the gene affected by any 
mutation. The authors have used genetic 
screens to identify several mutations that 
affect early cardiac function or morphology. Heart anomalies 
are easy to detect in zebraﬁ  sh, and can be examined in real time 
and in live specimens because the embryos develop outside the 
mother and are fully transparent. Using a ﬂ  uorescent molecular 
marker highly expressed in the ECs, the authors narrowed in on 
mutations that result in valve defects, and identiﬁ  ed a mutant 
they named cardiofunk (cfk), which was devoid of ECs. Genetic 
mapping of the cfk mutation revealed a single sequence change 
in a gene encoding a novel actin molecule that is most closely 
related to the sarcomeric actins found in sarcomeres, the 
contracting organelles of muscle cells. The result was surprising 
because contractions are not a property of endocardial cells. 
Using RNA detection assays, the authors 
show that the cfk gene is in fact expressed 
in the myocardium, rather than in the 
endocardium. It therefore appears that the 
inability to form ECs in cfk mutants does 
not reside in the endocardium per se, but 
is an indirect consequence of a myocardial 
anomaly.
The cfk mutation introduces a single 
amino acid change in the actin protein, 
and through detailed biochemical 
analyses, the authors show that the mutant 
actin is impaired in its ability to assemble 
into ﬁ  bers in vitro. What might be the 
consequence in vivo? The authors note 
that cfk mutants display abnormal heart 
contractions prior to the development of 
their EC defect. Support for the notion that 
myocardial contractions are required for 
EC formation comes from the examination 
of silent-heart (sih) mutants. sih mutants, 
which lack a heatbeat, have been shown 
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to harbor a mutation in troponin T, one 
of the motors of actin contractions; the 
authors ﬁ  nd that sih mutants also fail to 
develop ECs. The mechanisms linking 
myocardial contractions and cushion 
formation remain unclear. Blood ﬂ  ow 
may be a trigger, though the authors 
ﬁ  nd that ECs can develop even in the 
presence of pharmacological compounds 
that abolish it. The characterization of 
additional mutants should help answer 
this question.
Valve or septal defects represent 
40% of cardiac anomalies in humans. 
Bartman and colleagues suggest that, by 
analogy with zebraﬁ  sh, some may result 
from congenital defects affecting very 
early myocardial function. Their work 
thus opens new avenues for the early 
detection of human cardiac malfunctions 
and malformations.
Bartman T, Walsh EC, Wen K-K, McKane 
M, Ren J, et al. (2004) Early myocardial 
function affects endocardial cushion 
development in zebraﬁ  sh. DOI: 10.1371/
journal.pbio.0020129
Random Processes Underlie 
Most Evolutionary Changes in 
Gene Expression
Are evolutionary changes in gene 
expression determined mostly by natural 
selection or by random forces? It’s been 
some 150 years since Charles Darwin 
proposed that organisms adapt to their 
environment through the process of 
natural selection, yet the debate still 
rages, particularly at the molecular level. 
Darwinian selection was challenged in 
1983 by the Kimura neutral theory of 
molecular evolution, which argues that the 
majority of differences in DNA (nucleotide) 
and protein (amino acid) sequences 
within and between species have only 
minor or no selective effect and that these 
differences arise through mostly random 
processes. Mutations at the nucleotide 
level occur randomly and regularly. Some 
of them survive through generations, 
resulting in “ﬁ  xed’’ evolutionary changes 
between species. Two potential 
mechanisms can lead to the ﬁ  xation of a 
particular change: natural selection, which 
favors changes that convey a selective 
advantage, and stochastic (random) 
events, such as genetic drift (the random 
ﬂ  uctuations in genotype frequencies that 
occur from generation to generation in 
small populations).
DNA mutations can lead to changes 
in gene expression levels, some of which 
may convey a selective advantage to an 
organism and therefore become ﬁ  xed 
via natural selection. But since variation 
is produced at the genotype level, while 
selection is thought to operate largely at 
the phenotype level (that is, the physical 
manifestation of the genotype), it is 
reasonable to expect selection to be less 
apparent at the level of DNA sequence, 
and by extension, at the level of gene 
expression. Microarray technology 
has made it possible to systematically 
study expression levels of thousands of 
transcripts (the RNA copies of DNA that 
are translated into amino acid sequences) 
and to ask whether most changes of 
gene expression ﬁ  xed during evolution 
between species result from selective or 
stochastic processes.
To investigate this question, Philipp 
Khaitovich and colleagues analyzed 
the observed transcriptome differences 
among primate and mouse species as 
well as among various brain regions 
within a species. The team started out 
by analyzing the expression levels of 
some 12,000 genes in 
the prefrontal cortex 
of various primates, 
including humans. If 
evolutionary changes 
are caused by chance 
and not by natural 
selection, they will 
accumulate as a function 
of time rather than as 
a function of physical 
or behavioral changes 
in the organism. And 
that’s what the authors 
found: the changes in 
gene expression among 
the species progressed linearly with 
time, suggesting that gene expression in 
primate brains evolved in large part from 
random processes introducing selectively 
neutral, or biologically insigniﬁ  cant, 
changes.
According to neutral evolution theory, 
the same forces determine the rate of 
evolution both within and between 
species because similar random processes 
are at work on both levels. Consequently, 
genes that vary more within species 
should be more likely to vary between 
species. Comparing the expression levels 
of genes according to their variation 
within humans, the authors showed that 
genes with high variation among humans 
changed signiﬁ  cantly faster between 
species than genes with low variation 
among humans. The authors also 
compared changes observed in genes 
to changes observed in pseudogenes 
(genes that over evolutionary time 
acquire a mutation that renders them 
nonfunctional) and found no signiﬁ  cant 
difference between the two, suggesting 
again that most expression changes have 
no functional signiﬁ  cance.
While their analysis cannot exclude a 
role for natural selection, all the results 
are consistent with a neutral model of 
transcriptome evolution. This means 
that the majority of gene expression 
differences within and between species 
are not functional adaptations but 
selectively neutral and that we won’t be 
able to explain species differences based 
on variation in gene expression in general.
In addition to examining differences 
in gene expression in a particular tissue 
between species, the authors also discuss 
the evolution of different tissues within 
a species. The human brain is composed 
of regions that differ in function and 
histology (microscopic structure). Each 
of these regions acquired a functional or 
histological difference that separated it 
from its sister regions at some point in 
our evolutionary past. The authors show 
that the amount of change between 
regions correlates with tissue-divergence 
times estimated by other methods. If this 
ﬁ  nding applies for other tissues within 
and outside the brain, it could provide a 
method to reconstruct the evolution of 
tissues within a species.
Khaitovich P, Weiss G, Lachmann M, 
Hellmann I, Enard W, et al. (2004) A neutral 
model of transcriptome evolution. DOI: 
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To investigate the genetic 
underpinnings of a particular biological 
process, geneticists screen large 
collections of mutant organisms to 
characterize their physical defects. 
By comparing the genetic makeup of 
nonmutant (called wild-type) organisms 
to mutants, it’s possible to tease out 
the genes responsible for a defective 
appearance, or phenotype. In a classic 
study in the fruitﬂ  y, Christiane Nüsslein-
Volhard and Eric Weischaus bred many 
lines of ﬂ  ies with mutations that 
were lethal: the ﬂ  y embryos 
died, but not before displaying 
a wide range of developmental 
defects. Since it was known 
that the fruitﬂ  y needed only a 
single wild-type copy of these 
genes to survive, the mutations 
in these “embryonic lethals’’ 
had to be recessive, meaning 
that both copies, or alleles, of 
the gene had to be mutated 
for the lethal defect to appear. 
Nüsslein-Volhard and Weischaus’s 
work revealed many such 
recessive genes crucial to early 
development and earned them a 
Nobel Prize.
Among the model systems 
for studying development, the 
zebraﬁ  sh has become prized 
because its transparent embryo 
develops outside the mother’s 
body. The zebraﬁ  sh has helped 
biologists identify many genes 
involved in embryogenesis and, 
because it’s a vertebrate animal, 
has become a valuable resource 
for identifying genes involved in 
human disease. Now, a team led by Nancy 
Hopkins of the Massachusetts Institute of 
Technology, has created over 500 lines of 
zebraﬁ  sh with lesions in key embryogenic 
genes and used them to identify a group 
of genes that predispose the ﬁ  sh to 
cancer, with some surprising results.
All of the 500 lines created by the 
researchers carried a recessive embryonic 
lethal mutation; for about 400 of the 
lines, mutations in 300 distinct genes 
were identiﬁ  ed as the cause of the 
embryonic phenotype. During the 
process of cultivating some of these 
mutant lines, the Hopkins team noticed 
that an abnormally large percentage of 
ﬁ  sh experienced early mortality (in some 
cases, over 50% compared to the 10%–
15% seen in nonmutant ﬁ  sh), while the 
surviving ﬁ  sh in these lines developed 
large, highly invasive malignant tumors; 
both phenotypes persisted over 
successive generations. The tumors 
resembled malignant peripheral nerve 
sheath tumors (MPNSTs) that have been 
found in other ﬁ  sh species as well as in 
mammals. Suspecting that these mutant 
lines had elevated rates of cancer, the 
researchers investigated the genetic 
makeup of the ﬁ  sh and discovered 
to their surprise that each line was 
heterozygous for a mutation in a different 
ribosomal protein gene (rp)—that is, 
each line carried one healthy version 
and one defective version of a different 
rp gene. These proteins are components 
of ribosomes—the massive molecular 
complexes within cells that mediate 
protein synthesis—and are essential for 
embryonic development.
All of the rp mutations, the researchers 
report, either reduced or eliminated 
expression of the corresponding rp gene. 
In the case of “classic’’ tumor suppressor 
genes, the wild-type allele must be lost 
for the defective allele to set the stage 
for cancer. Here, the wild-type allele 
appeared to remain intact in the tumor 
cells, implicating the proteins 
as “haploinsufﬁ  cient’’ tumor 
suppressors—a reduction from 
two gene copies to one functional 
copy seems to be enough to 
increase the risk of cancer. 
Apart from the mutations in rp 
genes, the authors also found a 
loss-of-function mutation in a 
gene (called NF2) that acts as a 
tumor suppressor in mammals—
establishing the soundness of 
this approach for identifying 
mammalian cancer genes.
While these experiments do 
not explore how these mutations 
lead to cancer, the results suggest 
that some shared, ribosome-
associated function allows 
these genes to act as tumor 
suppressors and that disrupting 
this function somehow leads to 
tumor formation. Though it’s not 
clear what distinguishes the 11 rp 
genes whose mutations caused 
cancer from the ﬁ  ve other rp 
genes whose mutations did not, 
the authors raise a number of 
possibilities for future study. And 
given the high degree of conservation of 
genes and pathways among vertebrates, 
it’s likely that rp mutations also raise 
cancer risk in humans. Together, these 
results demonstrate that the tiny 
freshwater workhorse of developmental 
biology has a promising future as a 
model system for human cancer.
Amsterdam A, Sadler KC, Lai K, Farrington 
S, Bronson RT, et al. (2004) Many ribosomal 
protein genes are cancer genes in zebraﬁ  sh. 
DOI: 10.1371/journal.pbio.0020139
Defects in Ribosomal Protein Genes Cause Cancer in Zebraﬁ  sh
Zebraﬁ  sh tumors caused by mutation of a ribosomal 
protein gene